SARS-CoV-2 Virtual Biochemistry Labs on Bioinformatics and Drug Design

Autor/inn/en	Brandt, Gabriel S.; Novak, Walter R. P.
Titel	SARS-CoV-2 Virtual Biochemistry Labs on Bioinformatics and Drug Design
Quelle	In: Biochemistry and Molecular Biology Education, 49 (2021) 1, S.26-28 (3 Seiten)Infoseite zur Zeitschrift PDF als Volltext Verfügbarkeit
Zusatzinformation	ORCID (Novak, Walter R. P.)
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1470-8175
DOI	10.1002/bmb.21480
Schlagwörter	Leitfaden; Unterricht; Lehrer; Science Laboratories; Computer Simulation; Science Instruction; Biochemistry; COVID-19; Pandemics; School Closing; Educational Technology; Electronic Learning; College Science; Pharmacology; Information Science + Suchen Sie Ihr Suchwort? Lesson concept; Instruction; Unterrichtsentwurf; Unterrichtsprozess; Teacher; Teachers; Lehrerin; Lehrende; Computergrafik; Computersimulation; Teaching of science; Science education; Natural sciences Lessons; Naturwissenschaftlicher Unterricht; Biochemie; School closings; Schule; Schließung; Schließung (von Schulen); Unterrichtsmedien; Arzneikunde; Informationswissenschaft
Abstract	Colleges and universities are learning to provide relevant virtual lab experiences for students due to the COVID-19 pandemic. Even schools attempting in-person instruction often need to utilize virtual experiences for students absent due to quarantine or illness. Much of biochemistry is amenable to molecular visualization and/or computational study; however, many faculty face learning how to utilize new computational and molecular visualization software. We present a set of virtual lab exercises with detailed instructions to engage students in the discovery of novel antiviral compounds against the SARS-CoV-2 main protease. (As Provided).
Anmerkungen	Wiley. Available from: John Wiley & Sons, Inc. 111 River Street, Hoboken, NJ 07030. Tel: 800-835-6770; e-mail: cs-journals@wiley.com; Web site: https://www.wiley.com/en-us
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2024/1/01